Polysaccharide and nucleic acid formulations containing viscosity-lowering agents
US11471479B2 · kind B2 · utility
1Cited by
86References
32Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 30, 2015 |
| Grant date | Oct 18, 2022 |
| Priority date | — |
| Expiry date | Nov 15, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/36
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Concentrated, low-viscosity, low-volume liquid pharmaceutical formulations of polysaccharides and nucleic acids have been developed. Such formulations can be rapidly and conveniently administered by subcutaneous or intramuscular injection, rather than by lengthy intravenous infusion. These formulations include low-molecular-weight and/or high-molecular-weight polysaccharides and nucleic acids, and viscosity-lowering agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.